BRIEF—Veranova appoints new chief executive

Active pharmaceutical ingredient (API) manufacturing specialist Veranova has appointed Mike Riley as chief executive.

Formerly known as JM Health and part of Johnson Matthey, the company was sold to Altaris and rebranded as Veranova in mid-2022.

Mr Riley has spent around two decades in the contract development and manufacturing operations (CDMO) industry, most recently serving as president of biotherapeutics at Catalent.

Headquartered in Pennsylvania, USA, Veranova is focused on specialty and complex products and has operations in North America, Europe and Asia.